
|Articles|August 10, 2020
Efficacy and safety of intravitreal aflibercept (Eylea®) therapy using a proactive treat-and-extend regimen in neovascular AMD
Advertisement
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Loading Dose Adjustments and Treatment Switching Strategies in Retinal Vascular Diseases
2
How AI is reshaping ophthalmology in 2025 and beyond
3
Evaluating Retinal Drying, Durability and IOP Management with Second-Generation Anti-VEGF Therapies in Retinal Vascular Diseases
4
Seeing the difference: Multimodal imaging for AMD and GA
5







































